🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

13+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 13 of 13 recruiting trials for “Cancer of unknown primary site”

NARecruitingNCT07283939 ↗

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

👨‍⚕️ Gabriel A. Brooks, MD, MPH, Alliance for Clinical Trials in Oncology📍 271 sites📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT06995508 ↗

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

👨‍⚕️ Anurag K Singh, Roswell Park Cancer Institute📍 1 site📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT06868433 ↗

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

👨‍⚕️ Dong M. Shin, MD, FACP, FAAAS, Emory University📍 2 sites📅 Started May 2025View details ↗
Phase 3RecruitingNCT06589804 ↗

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

👨‍⚕️ Siddharth Sheth, Alliance for Clinical Trials in Oncology📍 175 sites📅 Started Mar 2025View details ↗
NARecruitingNCT06662058 ↗

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

👨‍⚕️ Nicole C Schmitt, MD, FACS, Emory University Hospital/Winship Cancer Institute📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06636734 ↗

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

👨‍⚕️ Nicole C Schmitt, D, FACS, Emory University Hospital/Winship Cancer Institute📍 2 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06644716 ↗

[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin

👨‍⚕️ Sophie Veldhuijzen van Zanten, Erasmus Medical Center📍 6 sites📅 Started Jul 2024View details ↗
Phase 1RecruitingNCT05172245 ↗

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

👨‍⚕️ Malcolm D Mattes, University Health Network Princess Margaret Cancer Center LAO📍 18 sites📅 Started Sep 2022View details ↗
Phase 1RecruitingNCT04754321 ↗

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

👨‍⚕️ Dukagjin M Blakaj, MD, PhD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started May 2022View details ↗
Phase 2RecruitingNCT05075980 ↗

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

👨‍⚕️ Scott C. Lester, M.D., Mayo Clinic in Rochester📍 9 sites📅 Started Feb 2022View details ↗
NARecruitingNCT04504604 ↗

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

👨‍⚕️ Razelle Kurzrock, M.D., Medical College of Wisconsin📍 1 site📅 Started Oct 2020View details ↗
NARecruitingNCT04475640 ↗

Cancer Genetic Testing in Ethnic Populations

👨‍⚕️ Jewel Samadder, M.D., Mayo Clinic📍 2 sites📅 Started Jan 2020View details ↗
RecruitingNCT03010150 ↗

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

👨‍⚕️ Eileen H Shinn, M.D. Anderson Cancer Center📍 1 site📅 Started Dec 2016View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →